VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here: IndiaNotes

Filter search : Quote Research All


Reports for search string : losses

Investment Idea: Sell Manappuram Finance, Tata Chemical; Buy Can Fin Homes
On a daily chart, index formed seven period bullish divergence hence the possibility of bounce back from current level can’t be ruled out. For the day, 10470 / 10565 are near term support whereas 1027...
Way2wealth, 20 Feb 2018
Cadila Healthcare 3QFY18 Results: High-value launches to help sustain growth momentum; maintain LONG
Cadila Healthcare’s (CDH) 3QFY18 sales at Rs 32.6bn (+41% yoy/+1 qoq) came in 5% below EE largely owing to market share losses in gLialda (partially compensated by gTamiflu).
Equirus Securities, 15 Feb 2018
GMDC Financial Results: Power a drag in FY18, but likely to improve significantly in FY19; Retain Long
GMDC posted 124% yoy growth in adj. EBITDA led by 45% yoy lignite volume growth, even as thermal power generation declined due to an extended shutdown.
Equirus Securities, 15 Feb 2018
Aster DM Healthcare IPO: Our recommendation “Avoid”
Moreover, looking at the financials of Aster ,though the business looks attractive & also Government focus on health sector in the current budget sounds positive for Aster but losses in H1FY18 with we...
Rudra Shares and Stock Brokers, 12 Feb 2018
Aster DM Healthcare IPO: High valuation at current level fails to infuse optimism; Avoid
Company is bringing the issue at price band of Rs 180-190 /sh at EV/EBIDTA multiple of 34-35. Although co’s business looks attractive but losses in H1FY18 with weak financial performance in FY17 & hig...
Hem Securities, 12 Feb 2018
Technical Picks: Nifty, Bank Nifty
Going forward, the last week low of 10276.30 will act as a near term support and any break below this level will drag index lower towards the strong support of 10033 which coincided with the previous ...
Way2wealth, 12 Feb 2018
Tata Motors Q3FY18: Revenues jumped by 58% yoy on strong volume growth; Maintain Buy
On overall basis, we expect an improved performance from TAMO in the ensuing quarters. We have reduced the JLR volumes estimate a bit for FY18E/19E on volume concerns in the UK and the US. Maintain Bu...
LKP Securities, 09 Feb 2018
How to trade Short Strangle?
Short Strangle is a market neutral strategy. For one to be profitable in this trade, the underlying (Nifty, Banknifty or any stock with liquid options) is expected to close within a range on expiry or...
Bonvista Financial Planners, 07 Feb 2018
Bajaj Auto Q3FY18: Estimates remain unchanged; ACCUMULATE
Overall volumes grew by 17.6% YoY (Motorcycles grew by 9.3% YoY & Commercial Vehicles grew by 78.2% YoY). EBITDA margins contracted on a YoY basis by 128bps to19.3%.
Way2wealth, 07 Feb 2018
Derivatives: Sell HCL tech, Buy Dish TV
After last 3 days of sharp correction, today markets will open on positive note on back of strong global indices but on higher side nifty will continue to see stiff resistance around 10640-10680 level...
Way2wealth, 07 Feb 2018
Apar Industries Q3 Results: Inline operating performance drag by weak conductor; maintain LONG
Despite higher volumes in conductor and TSO segments, Apar Industries’ (APR) 3QFY18 EBITDA slid 9% yoy on increased RM costs and highly competitive pricing in the conductor segment.
Equirus Securities, 05 Feb 2018
HSIL Q3FY18: Expect demand recovery in core businesses to be gradual - maintain ADD
HSIL’s 3QFY18 topline grew 14% yoy while PAT spiraled down 31% yoy, hit by one-off losses of Rs 69mn due to a fire at one of EVOK stores. EBITDA margins contracted 115bps yoy to 12.5%.
Equirus Securities, 05 Feb 2018
Arvind 3Q Results: B&R margin improvement continues, textile bottoming out - maintain ADD
After four quarters of EBITDA decline, Arvind Ltd. (ARVND) registered a 5% yoy EBITDA growth in 3QFY18 led by an improving performance in the B&R segment. Textile revenues grew 9% yoy but margins rema...
Equirus Securities, 05 Feb 2018
Derivatives: Markets can swing on either side on back of Union Budget announcements
On back of strong lobal cues, today domestic markets are expected to open on flat to positive note but thereafter will continue to trade in narrow band in first half of session. In second half of trad...
Way2wealth, 01 Feb 2018
Maruti Suzuki India Q3FY18: Proposed royalty reduction to cushion impact of rising commodity prices:revise to ADD
MSIL posted a strong 22% yoy EBITDA growth in 3QFY18, which came in 6% ahead of EE driven by the margin beat. Post a sharp run-up in the stock over the last three months, the valuations are inflated.
Equirus Securities, 31 Jan 2018
Music Broadcast 3Q weak but growth rate continues to top peers:reiterate ADD
Music Broadcast Limited’s (MBL) 3QFY18 revenues grew 5% yoy to Rs 762mn, coming in 6% below EE. However, according to the company, growth was better than the industry’s 2% yoy for the quarter.
Equirus Securities, 31 Jan 2018
Positional Call: Buy Shoppers Stop for an upside of 34% over a 3 month period
Shopper stop is expecting to show robust performance in coming quarters with a deal with Amazon which could be benenefial for the company as it can boost its sale.
Rudra Shares and Stock Brokers, 29 Jan 2018
Derivatives: Buy UPL, Sell Dabur
On back of strong global cues, February series is expected to open on positive note but will be quite volatile ahead of Union Budget scheduled on 1st Feb. Overall, market outlook remains bullish and a...
Way2wealth, 29 Jan 2018
Investment Idea: Buy MPhasis, Coal India; Sell Bata
Despite the F&O expiry; we haven’t seen any significant volatility in our market. Going forward, 11026 will act as an immediate support below which the next support comes near 10975. Higher side, 1111...
Way2wealth, 29 Jan 2018
Reliance Ind Q3FY18: EBITDA beat driven by petchem and RJio; reiterate ADD
RIL delivered a strong 52% yoy growth in its 3QFY18 EBITDA to Rs 176mn driven by the petchem segment and addition of RJio numbers. GRMs were in line but R-Jio continued to surprise with a positive PAT...
Equirus Securities, 25 Jan 2018
View All

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: